Holen Sie sich die Stockscreener-App
0.8201
0.87%
-0.0072
Schlusskurs vom Vortag:
$0.8273
Offen:
$0.7907
24-Stunden-Volumen:
39,096
Relative Volume:
0.15
Marktkapitalisierung:
$18.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.059
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
+2.96%
1M Leistung:
+15.49%
6M Leistung:
+6.40%
1J Leistung:
-21.14%
1-Tages-Spanne:
$0.7896
$0.8223
1-Wochen-Bereich:
$0.7407
$0.85
52-Wochen-Spanne:
$0.281
$3.79
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Compare KTTA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.8223 | 19.10M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.14 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.60 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
703.52 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.31 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
283.80 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Smart Money: Whats the beta of Pasithea Therapeutics Corp stock2026 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Pullback Watch: Is Pasithea Therapeutics Corp Equity Warrant stock overvalued or fairly priced2026 Price Action Summary & Stepwise Trade Signal Guides - baoquankhu1.vn
Fund Flows: Is Pasithea Therapeutics Corp Equity Warrant impacted by rising rates2026 Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
Will Pasithea Therapeutics Corp. Equity Warrant stock recover faster than market2026 Patterns & Entry Point Strategy Guides - Naître et grandir
RSI Check: What is Pasithea Therapeutics Corp Equity Warrants revenue forecastJuly 2025 Rallies & Expert Approved Momentum Ideas - baoquankhu1.vn
Earnings Recap: Whats the beta of Pasithea Therapeutics Corp stockMarket Risk Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Fed Watch: Whats the beta of Pasithea Therapeutics Corp Equity Warrant stockIPO Watch & Fast Entry High Yield Tips - baoquankhu1.vn
Certain Options of Pasithea Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 3-MAR-2026. - marketscreener.com
KTTA PE Ratio & Valuation, Is KTTA Overvalued - Intellectia AI
KTTA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Coastlands entities hold 2.39M shares in Pasithea Therapeutics (NASDAQ: KTTA) - Stock Titan
KTTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
What’s next for Pasithea Therapeutics Corp. stockTrade Entry Report & AI Enhanced Execution Alerts - mfd.ru
Pasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks
Pasithea Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
CVI and Heights disclose 3.8% Pasithea (KTTA) stake via warrant holdings - Stock Titan
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Investing News Network
Pasithea Therapeutics Corp. to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026 - Quiver Quantitative
NF1-PN drug developer Pasithea to present at Oppenheimer event - Stock Titan
Can Pasithea Therapeutics Corp. disrupt its industryQuarterly Market Summary & Daily Stock Trend Reports - mfd.ru
KTTA Should I Buy - Intellectia AI
Published on: 2026-02-12 18:27:19 - mfd.ru
Aug Mood: How does Pasithea Therapeutics Corp. correlate with NasdaqJuly 2025 Setups & Smart Investment Allocation Tips - mfd.ru
Published on: 2026-02-12 00:18:47 - mfd.ru
Why Pasithea Therapeutics Corp. stock is seen as undervaluedTrade Analysis Summary & AI Forecast for Swing Trade Picks - mfd.ru
What’s the beta of Pasithea Therapeutics Corp. stockWeekly Trading Summary & Precise Buy Zone Identification - mfd.ru
Why Pasithea Therapeutics Corp. Equity Warrant stock could be next big winnerJuly 2025 Price Swings & Daily Market Momentum Tracking - mfd.ru
Earnings Miss: Is Pasithea Therapeutics Corp Equity Warrant stock overvalued or fairly pricedJuly 2025 Trends & Capital Efficiency Focused Strategies - baoquankhu1.vn
Dividend Watch: What is the Moat Score of Pasithea Therapeutics Corp Equity WarrantGDP Growth & Stock Market Timing Techniques - baoquankhu1.vn
Aug Levels: Can Pasithea Therapeutics Corp disrupt its industryWeekly Loss Report & Weekly High Momentum Picks - baoquankhu1.vn
Meme Stocks: Can Beyond Meat Inc. navigate macro headwindsRate Cut & Weekly Sector Rotation Insights - baoquankhu1.vn
Jobs Data: What is the long term forecast for Pasithea Therapeutics Corp stockJuly 2025 Fed Impact & Long-Term Safe Investment Plans - baoquankhu1.vn
Weekly Earnings: Can Pasithea Therapeutics Corp disrupt its industryQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Institution Moves: Can Alerus Financial Corporation withstand a market correctionBond Market & Daily Entry Point Trade Alerts - baoquankhu1.vn
Is Pasithea Therapeutics Corp. stock influenced by commodity prices2025 Historical Comparison & Consistent Profit Trading Strategies - Mfd.ru
Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization - TipRanks
Fundamentals Check: Is POET benefiting from innovation trends2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Performance Recap: Should I average down on WRAP stockMarket Movers & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Aug Shorts: Can Pasithea Therapeutics Corp sustain earnings growth2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
How does SWVL compare to its peersEarnings Recap Summary & High Yield Stock Recommendations - baoquankhu1.vn
Published on: 2026-01-22 13:20:30 - baoquankhu1.vn
Aug Big Picture: Is Finward Bancorp benefiting from interest rate changes2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Pasithea Therapeutics regains Nasdaq compliance - MSN
New Highs: Can Pasithea Therapeutics Corp grow without external fundingJuly 2025 Closing Moves & Breakout Confirmation Trade Signals - baoquankhu1.vn
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway - TipRanks
Pasithea provides updates on clinical trials for MEK inhibitor drug By Investing.com - Investing.com Canada
Pasithea provides updates on clinical trials for MEK inhibitor drug - Investing.com
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines - Investing News Network
Pasithea Therapeutics Updates Clinical Trial Timelines for PAS-004 in Neurofibromatosis and Advanced Cancer - Quiver Quantitative
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pasithea Therapeutics Corp-Aktie (KTTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
73,334 |
| Dumesnil Simon | Director |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
35,833 |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):